What does the evidence say about Cinnamon Glucose Meta-Analysis?

Updated October 2026

Quick Answer

Cinnamon Glucose Meta-Analysis has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: 9 11 Although numerous studies have reported beneficial metabolic outcomes associated with cinnamon supplementation in individuals with metabolic diseases (–), findings across trials remain inconsistent.

Key Takeaways

  • 019 11 Although numerous studies have reported beneficial metabolic outcomes associated with cinnamon supplementation in individuals with metabolic diseases (–), findings across trials remain inconsistent. [Gou Haobo (2025)]
  • 02Therefore, an umbrella review is warranted to systematically evaluate and synthesize evidence from existing systematic reviews and meta-analyses. [Gou Haobo (2025)]
  • 03Additionally, we seek to explore whether the effectiveness of cinnamon varies according to dosage, duration of intervention, or underlying disease type, thereby providing more robust evidence to guide clinical practice and future research. [Gou Haobo (2025)]
  • 041 1 2 3 4 Metabolic diseases comprise a group of conditions characterized by disturbances in glucose, lipid, or protein metabolism (). [Gou Haobo (2025)]
The current Migaku evidence database contains 2 reusable source documents for Cinnamon Glucose Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - 9 11 Although numerous studies have reported beneficial metabolic outcomes associated with cinnamon supplementation in individuals with metabolic diseases (–), findings across trials remain inconsistent. [Gou Haobo (2025); evidence level 2] - Therefore, an umbrella review is warranted to systematically evaluate and synthesize evidence from existing systematic reviews and meta-analyses. [Gou Haobo (2025); evidence level 2] - Additionally, we seek to explore whether the effectiveness of cinnamon varies according to dosage, duration of intervention, or underlying disease type, thereby providing more robust evidence to guide clinical practice and future research. [Gou Haobo (2025); evidence level 2] - 1 1 2 3 4 Metabolic diseases comprise a group of conditions characterized by disturbances in glucose, lipid, or protein metabolism (). [Gou Haobo (2025); evidence level 2] - Emerging evidence suggests that membrane signaling mechanisms, in particular, ion channels and G protein-coupled receptors (GPCRs) on the cell surface, serve as critical upstream regulators of metabolic functions. [Tjandrawinata Raymond Rubianto (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. The effects of cinnamon on patients with metabolic diseases: an umbrella review of meta-analyses of randomized controlled trials
  2. Cinnamon-Derived Phytonutrients as Modulators of Ion Channels and G Protein-Coupled Receptor Signaling in Metabolic Diseases